Skip to Main Content
Diseases of the Nervous System, Phase Pilot

US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

What is the purpose of this trial?

The eShunt® System is a minimally invasive method of treating communicating hydrocephalus. The eShunt System includes a proprietary eShunt Delivery System and the eShunt Implant, a permanent implant deployed in a minimally invasive, neuro-interventional procedure. The eShunt System is intended to shunt cerebrospinal fluid from the intracranial subarachnoid space to the venous system for the treatment of patients with normal pressure hydrocephalus, reducing disability due to symptoms including one or more of gait disturbance, cognitive dysfunction and urinary incontinence.

  • Trial with
    CereVasc, Inc.
  • Ages
    65 years - 85 years
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Lindsey Fraczkiewicz

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    02/02/2024
  • Study HIC
    #2000032178